Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Utility of emergency call centre, dispatch and ambulance data for syndromic surveillance of infectious diseases: a scoping review.

Duijster JW, Doreleijers SD, Pilot E, van der Hoek W, Kommer GJ, van der Sande MA, Krafft T, van Asten LC.

Eur J Public Health. 2019 Oct 12. pii: ckz177. doi: 10.1093/eurpub/ckz177. [Epub ahead of print]

PMID:
31605491
2.

Estimating Morbidity Rates Based on Routine Electronic Health Records in Primary Care: Observational Study.

Nielen MMJ, Spronk I, Davids R, Korevaar JC, Poos R, Hoeymans N, Opstelten W, van der Sande MAB, Biermans MCJ, Schellevis FG, Verheij RA.

JMIR Med Inform. 2019 Jul 26;7(3):e11929. doi: 10.2196/11929.

3.

Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis.

Lin C, Slama J, Gonzalez P, Goodman MT, Xia N, Kreimer AR, Wu T, Hessol NA, Shvetsov Y, Ortiz AP, Grinsztejn B, Moscicki AB, Heard I, Del Refugio González Losa M, Kojic EM, Schim van der Loeff MF, Wei F, Longatto-Filho A, Mbulawa ZA, Palefsky JM, Sohn AH, Hernandez BY, Robison K, Simpson S Jr, Conley LJ, de Pokomandy A, van der Sande MAB, Dube Mandishora RS, Volpini LPB, Pierangeli A, Romero B, Wilkin T, Franceschi S, Hidalgo-Tenorio C, Ramautarsing RA, Park IU, Tso FK, Godbole S, D'Hauwers KWM, Sehnal B, Menezes LJ, Heráclio SA, Clifford GM.

Lancet Infect Dis. 2019 Aug;19(8):880-891. doi: 10.1016/S1473-3099(19)30164-1. Epub 2019 Jun 13.

4.

Bivalent Vaccine Effectiveness Against Anal Human Papillomavirus Positivity Among Female Sexually Transmitted Infection Clinic Visitors in the Netherlands.

Woestenberg PJ, King AJ, Van Benthem BHB, Leussink S, Van der Sande MAB, Hoebe CJPA, Bogaards JA; Medical Microbiological Laboratories and the Public Health Services.

J Infect Dis. 2019 Apr 23. pii: jiz187. doi: 10.1093/infdis/jiz187. [Epub ahead of print]

PMID:
31100134
5.

Recurrent Cholera Outbreaks, Democratic Republic of the Congo, 2008-2017.

Ingelbeen B, Hendrickx D, Miwanda B, van der Sande MAB, Mossoko M, Vochten H, Riems B, Nyakio JP, Vanlerberghe V, Lunguya O, Jacobs J, Boelaert M, Kebela BI, Bompangue D, Muyembe JJ.

Emerg Infect Dis. 2019 May;25(5):856-864. doi: 10.3201/eid2505.181141.

6.

Salmonella Typhi From Blood Cultures in the Democratic Republic of the Congo: A 10-Year Surveillance.

Tack B, Phoba MF, Van Puyvelde S, Kalonji LM, Hardy L, Barbé B, Van der Sande MAB, Monsieurs E, Deborggraeve S, Lunguya O, Jacobs J.

Clin Infect Dis. 2019 Mar 7;68(Supplement_2):S130-S137. doi: 10.1093/cid/ciy1116.

7.

Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial.

Hoenderboom BM, van Benthem BHB, van Bergen JEAM, Dukers-Muijrers NHTM, Götz HM, Hoebe CJPA, Hogewoning AA, Land JA, van der Sande MAB, Morré SA, van den Broek IVF.

Sex Transm Infect. 2019 Jun;95(4):300-306. doi: 10.1136/sextrans-2018-053778. Epub 2019 Jan 3.

8.

Assessment of herd effects among women and heterosexual men after girls-only HPV16/18 vaccination in the Netherlands: A repeated cross-sectional study.

Woestenberg PJ, Bogaards JA, King AJ, Leussink S, van der Sande MA, Hoebe CJ, van Benthem BH; Medical Microbiological Laboratories and the Public Health Services.

Int J Cancer. 2019 Jun 1;144(11):2718-2727. doi: 10.1002/ijc.31989. Epub 2018 Dec 21.

9.

Childhood infections and common carotid intima media thickness in adolescence.

Prins-van Ginkel AC, Bruijning-Verhagen PCJ, Wijga AH, Bots ML, Gehring U, van der Hoek W, Koppelman GH, van Rossem L, Uiterwaal CSPM, Smit HA, van der Sande MAB.

Epidemiol Infect. 2018 Nov 8:1-7. doi: 10.1017/S095026881800287X. [Epub ahead of print]

10.

Trends and determinants of antimicrobial susceptibility of Neisseria gonorrhoeae in the Netherlands, 2007 to 2015.

Hofstraat SH, Götz HM, van Dam AP, van der Sande MA, van Benthem BH.

Euro Surveill. 2018 Sep;23(36). doi: 10.2807/1560-7917.ES.2018.23.36.1700565.

11.

Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.

Harder T, Wichmann O, Klug SJ, van der Sande MAB, Wiese-Posselt M.

BMC Med. 2018 Jul 18;16(1):110. doi: 10.1186/s12916-018-1098-3. Review.

12.

Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study.

Donken R, Tami A, Knol MJ, Lubbers K, van der Sande MAB, Nijman HW, Daemen T, Weijmar Schultz WCM, de Melker HE.

BMC Public Health. 2018 Jul 5;18(1):837. doi: 10.1186/s12889-018-5745-6.

13.

Detection of Incident Anal High-Risk Human Papillomavirus DNA in Men Who Have Sex With Men: Incidence or Reactivation?

Twisk DE, van der Sande MAB, van Eeden A, Heideman DAM, van der Klis FRM, de Vries HJC, Schim van der Loeff MF.

J Infect Dis. 2018 Aug 24;218(7):1018-1026. doi: 10.1093/infdis/jiy276.

PMID:
29771378
14.

Newly identified risk factors for MRSA carriage in The Netherlands.

Lekkerkerk WSN, Haenen A, van der Sande MAB, Leenstra T, de Greeff S, Timen A, Tjon-A-Tsien A, Richardus JH, van de Sande-Bruinsma N, Vos MC.

PLoS One. 2017 Nov 30;12(11):e0188502. doi: 10.1371/journal.pone.0188502. eCollection 2017.

15.

National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands.

Altorf-van der Kuil W, Schoffelen AF, de Greeff SC, Thijsen SF, Alblas HJ, Notermans DW, Vlek AL, van der Sande MA, Leenstra T; The National Amr Surveillance Study Group.

Euro Surveill. 2017 Nov;22(46). doi: 10.2807/1560-7917.ES.2017.22.46.17-00062.

16.

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.

Woestenberg PJ, King AJ, van Benthem BHB, Donken R, Leussink S, van der Klis FRM, de Melker HE, van der Sande MAB, Hoebe CJPA, Bogaards JA; Medical Microbiological Laboratories and the Public Health Services.

J Infect Dis. 2018 Jan 4;217(2):213-222. doi: 10.1093/infdis/jix582.

17.

Estimated incidence and number of outpatient visits for seasonal influenza in 2015-2016 in Beijing, China.

Wu S, VAN Asten L, Wang L, McDonald SA, Pan Y, Duan W, Zhang L, Sun Y, Zhang Y, Zhang X, Pilot E, Krafft T, VAN DER Hoek W, VAN DER Sande MAB, Yang P, Wang Q.

Epidemiol Infect. 2017 Dec;145(16):3334-3344. doi: 10.1017/S0950268817002369. Epub 2017 Nov 9.

PMID:
29117874
18.

Screening for HIV, hepatitis B and syphilis on dried blood spots: A promising method to better reach hidden high-risk populations with self-collected sampling.

van Loo IHM, Dukers-Muijrers NHTM, Heuts R, van der Sande MAB, Hoebe CJPA.

PLoS One. 2017 Oct 20;12(10):e0186722. doi: 10.1371/journal.pone.0186722. eCollection 2017.

19.

Long-term impairment attributable to congenital cytomegalovirus infection: a retrospective cohort study.

Korndewal MJ, Oudesluys-Murphy AM, Kroes ACM, van der Sande MAB, de Melker HE, Vossen ACTM.

Dev Med Child Neurol. 2017 Dec;59(12):1261-1268. doi: 10.1111/dmcn.13556. Epub 2017 Oct 9.

20.

Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands.

Tielemans SMAJ, de Melker HE, Hahné SJM, Boef AGC, van der Klis FRM, Sanders EAM, van der Sande MAB, Knol MJ.

BMJ. 2017 Aug 30;358:j3862. doi: 10.1136/bmj.j3862.

21.

Anal HPV 16 and 18 viral load: A comparison between HIV-negative and -positive MSM and association with persistence.

Marra E, King A, van Logchem E, van der Weele P, Mooij SH, Heijman T, Meijer CJLM, Verhagen DWM, van der Sande MAB, Schim van der Loeff MF.

J Med Virol. 2018 Jan;90(1):76-83. doi: 10.1002/jmv.24898. Epub 2017 Oct 17.

PMID:
28700080
22.

Comparing national infectious disease surveillance systems: China and the Netherlands.

Vlieg WL, Fanoy EB, van Asten L, Liu X, Yang J, Pilot E, Bijkerk P, van der Hoek W, Krafft T, van der Sande MA, Liu QY.

BMC Public Health. 2017 May 8;17(1):415. doi: 10.1186/s12889-017-4319-3.

23.

The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women.

Hoenderboom BM, van Oeffelen AA, van Benthem BH, van Bergen JE, Dukers-Muijrers NH, Götz HM, Hoebe CJ, Hogewoning AA, van der Klis FR, van Baarle D, Land JA, van der Sande MA, van Veen MG, de Vries F, Morré SA, van den Broek IV.

BMC Infect Dis. 2017 Apr 11;17(1):264. doi: 10.1186/s12879-017-2376-y.

24.

No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.

Woestenberg PJ, King AJ, van der Sande MA, Donken R, Leussink S, van der Klis FR, Hoebe CJ, Bogaards JA, van Benthem BH; Medical Microbiological Laboratories; Public Health Services.

J Infect. 2017 Apr;74(4):393-400. doi: 10.1016/j.jinf.2017.01.007. Epub 2017 Jan 23.

25.

Coxiella burnetii (Q fever) prevalence in associated populations of humans and small ruminants in The Gambia.

Bok J, Hogerwerf L, Germeraad EA, Roest HI, Faye-Joof T, Jeng M, Nwakanma D, Secka A, Stegeman A, Goossens B, Wegmüller R, van der Sande MA, van der Hoek W, Secka O.

Trop Med Int Health. 2017 Mar;22(3):323-331. doi: 10.1111/tmi.12827. Epub 2017 Jan 22.

26.

Outbreaks of syphilis among men who have sex with men attending STI clinics between 2007 and 2015 in the Netherlands: a space-time clustering study.

van Aar F, den Daas C, van der Sande MAB, Soetens LC, de Vries HJC, van Benthem BHB.

Sex Transm Infect. 2017 Sep;93(6):390-395. doi: 10.1136/sextrans-2016-052754. Epub 2016 Dec 16.

PMID:
27986969
27.

Low Seroprevalence of Brucellosis in Humans and Small Ruminants in the Gambia.

Germeraad EA, Hogerwerf L, Faye-Joof T, Goossens B, van der Hoek W, Jeng M, Lamin M, Manneh IL, Nwakanma D, Roest HI, Secka A, Stegeman A, Wegmüller R, van der Sande MA, Secka O.

PLoS One. 2016 Nov 8;11(11):e0166035. doi: 10.1371/journal.pone.0166035. eCollection 2016.

28.

Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands.

Xiridou M, Lugnér A, de Vries HJ, van Bergen JE, Götz HM, van Benthem BH, Wallinga J, van der Sande MA.

Sex Transm Dis. 2016 Sep;43(9):542-8. doi: 10.1097/OLQ.0000000000000480.

PMID:
27513379
29.

Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period.

Woestenberg PJ, Tjhie JH, de Melker HE, van der Klis FR, van Bergen JE, van der Sande MA, van Benthem BH.

BMC Infect Dis. 2016 Aug 2;16:364. doi: 10.1186/s12879-016-1707-8.

30.

Long-term outcomes of slipped capital femoral epiphysis treated with in situ pinning.

de Poorter JJ, Beunder TJ, Gareb B, Oostenbroek HJ, Bessems GH, van der Lugt JC, Maathuis PG, van der Sande MA.

J Child Orthop. 2016 Oct;10(5):371-9. doi: 10.1007/s11832-016-0759-z. Epub 2016 Jul 20.

31.

Correction: Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands.

King AJ, Sonsma JA, Vriend HJ, van der Sande MA, Feltkamp MC, Boot HJ, Koopmans MP; Medical Microbiological Laboratories and Municipal Health Services.

PLoS One. 2016 Apr 28;11(4):e0154977. doi: 10.1371/journal.pone.0154977. eCollection 2016.

32.

Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands.

King AJ, Sonsma JA, Vriend HJ, van der Sande MA, Feltkamp MC, Boot HJ, Koopmans MP; Medical Microbiological Laboratories and Municipal Health Services.

PLoS One. 2016 Apr 12;11(4):e0152782. doi: 10.1371/journal.pone.0152782. eCollection 2016. Erratum in: PLoS One. 2016;11(4):e0154977.

33.
34.

Young male sex workers are at high risk for sexually transmitted infections, a cross-sectional study from Dutch STI clinics, the Netherlands, 2006-2012.

Fournet N, Koedijk FD, van Leeuwen AP, van Rooijen MS, van der Sande MA, van Veen MG.

BMC Infect Dis. 2016 Feb 4;16:63. doi: 10.1186/s12879-016-1388-3.

35.

Nosocomial transmission of avian influenza virus A (H7N9).

van der Sande MA, van der Hoek W.

BMJ. 2015 Nov 19;351:h5980. doi: 10.1136/bmj.h5980. No abstract available.

PMID:
26586650
36.

Disease burden of congenital cytomegalovirus infection at school entry age: study design, participation rate and birth prevalence.

Korndewal MJ, Vossen AC, Cremer J, VAN Binnendijk RS, Kroes AC, VAN DER Sande MA, Oudesluys-Murphy AM, DE Melker HE.

Epidemiol Infect. 2016 May;144(7):1520-7. doi: 10.1017/S0950268815002708. Epub 2015 Nov 11.

PMID:
26554756
37.

To notify or not to notify: decision aid for policy makers on whether to make an infectious disease mandatorily notifiable.

Bijkerk P, Fanoy EB, Kardamanidis K, van der Plas SM, Te Wierik MJ, Kretzschmar ME, Haringhuizen GB, van Vliet HJ, van der Sande MA.

Euro Surveill. 2015;20(34):30003. doi: 10.2807/1560-7917.ES.2015.20.34.30003.

38.

Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey.

van den Broek IV, Sfetcu O, van der Sande MA, Andersen B, Herrmann B, Ward H, Götz HM, Uusküla A, Woodhall SC, Redmond SM, Amato-Gauci AJ, Low N, van Bergen JE.

Eur J Public Health. 2016 Jun;26(3):382-8. doi: 10.1093/eurpub/ckv196. Epub 2015 Oct 24.

39.

The effect of HIV infection on anal and penile human papillomavirus incidence and clearance: a cohort study among MSM.

Mooij SH, van Santen DK, Geskus RB, van der Sande MA, Coutinho RA, Stolte IG, Snijders PJ, Meijer CJ, Speksnijder AG, de Vries HJ, King AJ, van Eeden A, van der Loeff MF.

AIDS. 2016 Jan 2;30(1):121-32. doi: 10.1097/QAD.0000000000000909.

PMID:
26474302
40.

Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection.

Vriend HJ, Bogaards JA, van Bergen JE, Brink AA, van den Broek IV, Hoebe CJ, King AJ, van der Sande MA, Wolffs PF, de Melker HE; Medical Microbiological Laboratories and the CSI group.

Cancer Med. 2015 Oct;4(10):1589-98. doi: 10.1002/cam4.496. Epub 2015 Jul 21.

41.

Association of HIV Infection With Anal and Penile Low-Risk Human Papillomavirus Infections Among Men Who Have Sex With Men in Amsterdam: The HIV & HPV in MSM Study.

Welling CA, Mooij SH, van der Sande MA, van Rooijen MS, Vermeulen-Oost WF, King AJ, van Eeden A, Heideman DA, Stolte IG, Schim van der Loeff MF.

Sex Transm Dis. 2015 Jun;42(6):297-304. doi: 10.1097/OLQ.0000000000000278.

PMID:
25970305
42.

Delayed linkage to care in one-third of HIV-positive individuals in the Netherlands.

van Veen MG, Trienekens SC, Heijman T, Gotz HM, Zaheri S, Ladbury G, de Wit J, Fennema JS, de Wolf F, van der Sande MA.

Sex Transm Infect. 2015 Dec;91(8):603-9. doi: 10.1136/sextrans-2014-051980. Epub 2015 May 11.

PMID:
25964506
43.

Gender-specific mortality in DTP-IPV- and MMR±MenC-eligible age groups to determine possible sex-differential effects of vaccination: an observational study.

Schurink-van't Klooster TM, Knol MJ, de Melker HE, van der Sande MA.

BMC Infect Dis. 2015 Mar 24;15:148. doi: 10.1186/s12879-015-0898-8.

44.

Chlamydia screening is not cost-effective at low participation rates: evidence from a repeated register-based implementation study in The Netherlands.

de Wit GA, Over EA, Schmid BV, van Bergen JE, van den Broek IV, van der Sande MA, Welte R, Op de Coul EL, Kretzschmar ME.

Sex Transm Infect. 2015 Sep;91(6):423-9. doi: 10.1136/sextrans-2014-051677. Epub 2015 Mar 10.

PMID:
25759475
45.

Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study.

van Aar F, Mooij SH, van der Sande MA, Meijer CJ, King AJ, Verhagen DW, Heijman T, Coutinho RA, Schim van der Loeff MF.

BMC Infect Dis. 2014 Dec 31;14:668. doi: 10.1186/s12879-014-0668-z.

46.

Repeated STI and HIV testing among HIV-negative men who have sex with men attending a large STI clinic in Amsterdam: a longitudinal study.

Vriend HJ, Stolte IG, Heijne JC, Heijman T, De Vries HJ, Geskus RB, Van der Sande MA, Prins M.

Sex Transm Infect. 2015 Jun;91(4):294-9. doi: 10.1136/sextrans-2014-051786. Epub 2014 Dec 10.

PMID:
25504922
47.

Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function.

Mooij HL, Cabrales P, Bernelot Moens SJ, Xu D, Udayappan SD, Tsai AG, van der Sande MA, de Groot E, Intaglietta M, Kastelein JJ, Dallinga-Thie GM, Esko JD, Stroes ES, Nieuwdorp M.

J Am Heart Assoc. 2014 Dec 2;3(6):e001274. doi: 10.1161/JAHA.114.001274.

48.

Travel-related MERS-CoV cases: an assessment of exposures and risk factors in a group of Dutch travellers returning from the Kingdom of Saudi Arabia, May 2014.

Fanoy EB, van der Sande MA, Kraaij-Dirkzwager M, Dirksen K, Jonges M, van der Hoek W, Koopmans MP, van der Werf D, Sonder G, van der Weijden C, van der Heuvel J, Gelinck L, Bouwhuis JW, van Gageldonk-Lafeber AB.

Emerg Themes Epidemiol. 2014 Oct 17;11:16. doi: 10.1186/1742-7622-11-16. eCollection 2014.

49.

Public health measures to control the spread of antimicrobial resistance in Neisseria gonorrhoeae in men who have sex with men.

Xiridou M, Soetens LC, Koedijk FD, VAN DER Sande MA, Wallinga J.

Epidemiol Infect. 2015 Jun;143(8):1575-84. doi: 10.1017/S0950268814002519. Epub 2014 Oct 2.

PMID:
25275435
50.

Effectiveness of post-exposition prophylaxis with oseltamivir in nursing homes: a randomised controlled trial over four seasons.

van der Sande MA, Meijer A, Sen-Kerpiclik F, Enserink R, Cools HJ, Overduin P, Ferreira JM, Veldman-Ariessen MJ.

Emerg Themes Epidemiol. 2014 Sep 10;11:13. doi: 10.1186/1742-7622-11-13. eCollection 2014.

Supplemental Content

Loading ...
Support Center